Clinical Effect Observation of Fuzheng Xiaoai Mixture Combined with Chemotherapy of GP Regimen in Treating Patients with Advanced Non-samll Cell Lung Cancer
|更新时间:2024-01-04
|
Clinical Effect Observation of Fuzheng Xiaoai Mixture Combined with Chemotherapy of GP Regimen in Treating Patients with Advanced Non-samll Cell Lung Cancer
Chinese Journal of Experimental Traditional Medical FormulaeVol. 18, Issue 22, Pages: 328-331(2012)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2012
稿件说明:
移动端阅览
DENG Xiao-ming, DU Ji-ying, ZENG Chen, et al. Clinical Effect Observation of Fuzheng Xiaoai Mixture Combined with Chemotherapy of GP Regimen in Treating Patients with Advanced Non-samll Cell Lung Cancer[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(22): 328-331.
DOI:
DENG Xiao-ming, DU Ji-ying, ZENG Chen, et al. Clinical Effect Observation of Fuzheng Xiaoai Mixture Combined with Chemotherapy of GP Regimen in Treating Patients with Advanced Non-samll Cell Lung Cancer[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(22): 328-331.DOI:
Clinical Effect Observation of Fuzheng Xiaoai Mixture Combined with Chemotherapy of GP Regimen in Treating Patients with Advanced Non-samll Cell Lung Cancer
Objective:To observe the clinical efficacy of Fuzheng Xiaoai mixture combined with gemcitabine-ciplatimon(GP) regimen in the treatment of advanced non-small cell lung cancer(NSCLC). Method: Sixty patients with advanced NSCLC were randomized into two groups
each 30 cases. The control group was treated with GP regimen
the treatment group was trea-ted with Fuzheng Xiaoai mixture combined with GP program. A treatment cycle lasted 21 days
at least two cycles. Result: The effective rate was 23.33%
16.67% in the treatment group and the control group
respectively
but there was no significant difference between two groups. But the treatment group has significant differences compared with the control group in the quality of life score
immune function
toxicity and adverse in-cidence
and the change of VEGF levels in peripheral blood (P<0.05). Conclusion: Fuzheng Xiaoai mixture combined with GP program can improve the quality of life in advanced non-small cell lung cancer patients
immune function and can reduce toxicity and increase efficiency.